Publication:
Amino acid substitutions in GyrA affect quinolone susceptibility in Salmonella typhimurium

dc.contributor.authorSiriporn Kongsoien_US
dc.contributor.authorRuchirada Changkwanyeunen_US
dc.contributor.authorKazumasa Yokoyamaen_US
dc.contributor.authorChie Nakajimaen_US
dc.contributor.authorKanjana Changkaewen_US
dc.contributor.authorOrasa Suthienkulen_US
dc.contributor.authorYasuhiko Suzukien_US
dc.contributor.otherHokkaido Universityen_US
dc.contributor.otherKissei Pharmaceutical Co., Ltd.en_US
dc.contributor.otherThammasat Universityen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-12-11T02:32:13Z
dc.date.accessioned2019-03-14T08:04:27Z
dc.date.available2018-12-11T02:32:13Z
dc.date.available2019-03-14T08:04:27Z
dc.date.issued2016-10-01en_US
dc.description.abstractCopyright © 2015 John Wiley & Sons, Ltd. The prevalence of quinolone-resistant Salmonella has become a public health concern. Amino acid substitutions have generally been found within the quinolone resistance-determining region in subunit A of DNA gyrase (GyrA) of Salmonella Typhimurium. However, direct evidence of the contribution of these substitutions to quinolone resistance remains to be shown. To investigate the significance of amino acid substitutions in S. Typhimurium GyrA to quinolone resistance, we expressed recombinant wild-type (WT) and five mutant DNA gyrases in Escherichia coli and characterized them in vitro. WT and mutant DNA gyrases were reconstituted in vitro by mixing recombinant subunits A and B of DNA gyrase. The correlation between the amino acid substitutions and resistance to quinolones ciprofloxacin, levofloxacin, nalidixic acid, and sitafloxacin was assessed by quinolone-inhibited supercoiling assays. All mutant DNA gyrases showed reduced susceptibility to all quinolones when compared with WT DNA gyrases. DNA gyrase with a double amino acid substitution in GyrA, serine to phenylalanine at codon 83 and aspartic acid to asparagine at 87 (GyrA-S83F-D87N), exhibited the lowest quinolone susceptibility amongst all mutant DNA gyrases. The effectiveness of sitafloxacin was shown by the low inhibitory concentration required for mutant DNA gyrases, including the DNA gyrase with GyrA-S83F-D87N. We suggest sitafloxacin as a candidate drug for the treatment of salmonellosis caused by ciprofloxacin-resistant S. Typhimurium. Copyright © 2015 John Wiley & Sons, Ltd.en_US
dc.identifier.citationDrug Testing and Analysis. Vol.8, No.10 (2016), 1065-1070en_US
dc.identifier.doi10.1002/dta.1910en_US
dc.identifier.issn19427611en_US
dc.identifier.issn19427603en_US
dc.identifier.other2-s2.0-84949266626en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/43392
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84949266626&origin=inwarden_US
dc.subjectChemistryen_US
dc.subjectEnvironmental Scienceen_US
dc.titleAmino acid substitutions in GyrA affect quinolone susceptibility in Salmonella typhimuriumen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84949266626&origin=inwarden_US

Files

Collections